Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

Author： Friese A.   Seiller E.   Quack G.   Lorenz B.   Kreuter J.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.49, Iss.2, 2000-03, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of farmorubicin both free and associated with poly(butylcyanoacrylate) nanoparticles on phagocytic and NK activity of peritoneal exudate cells from tumor-bearing mice

By Simeonova Margarita Y.   Antcheva Margarita N.  

Journal of Drug Targeting, Vol. 15, Iss. 4, 2007-05 ,pp. : 302-310

Informa Healthcare

Access to resources Recommend Favorite

Interaction of Dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system

By Striem S.   Bar-Joseph A.   Berkovitch Y.   Biegon A.  

European Journal of Pharmacology, Vol. 338, Iss. 3, 1997-11 ,pp. : 205-213

Elsevier

Access to resources Recommend Favorite

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

By Eshhar N.   Striem S.   Kohen R.   Tirosh O.   Biegon A.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 19-29

Elsevier

Access to resources Recommend Favorite

Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action

By  

Current Drug Targets, Vol. 2, Iss. 3, 2001-09 ,pp. : 285-298

Bentham Science Publishers

Access to resources Recommend Favorite

LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs

By Czuczwar S.J.   Swiader M.   Kuzniar H.   Gasior M.   Kleinrok Z.  

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite